Balance Sheet Details (Details) - Schedule of Accrued Expenses - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Schedule of Accrued Expenses [Abstract]
Accrued research and development	$ 475,434	$ 847,747
Accrued deferred offering costs	125,000	125,000
Accrued compensation	349,200	1,132,859
Accrued professional fees	246,314
Accrued franchise taxes	89,600	177,600
Other accrued expenses	134,261	125,922
Total	$ 1,419,809	$ 2,409,128